allogeneic GM-CSF-secreting breast cancer vaccine SV-BR-1-GM
A vaccine consisting of irradiated allogeneic breast cancer cells, derived from the breast cancer cell line SV-BR-1 that are transfected with the immunostimulant granulocyte-macrophage colony-stimulating factor (GM-CSF; CSF2) gene, with potential immunostimulating and antineoplastic activities. Upon intradermal administration of the allogeneic GM-CSF-secreting breast cancer vaccine SV-BR-1-GM, the genetically-modified cells secrete GM-CSF. This potentiates a tumor-specific cytotoxic T-lymphocyte (CTL) immune response against breast cancer cells.
| Synonym: | Breast Cancer Vaccine SV-BR-1-GM GM-CSF gene-transfected breast cancer vaccine SV-BR-1-GM SV-BR-1 breast cancer cell line vaccine SV-BR-1-GM SV-BR-1-GM vaccine |
|---|---|
| US brand name: | Bria-IMT |